SlideShare a Scribd company logo
EVICEL Fibrin Sealant (Human) Product Information EVICEL TM  Fibrin Sealant (Human) PSR Sales Training Module
Training Road Map ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Biosurgicals Products EVICEL* FIBRIN SEALANT (HUMAN) ORC (Oxidized Regenerated  Cellulose) GELATIN FLOWABLE GELATIN COLLAGEN FIBRIN SEALANT SURGICEL* Hemostats SURGICEL FIBRILLAR* Hemostats SURGICEL NU-KNIT* Hemostats SURGIFOAM* GELATIN SPONGE & POWDER Hemostats INSTAT*  MICROFIBRILLARCOLLAGEN Hemostats SURGIFOAM* POWDER Kit SURGIFLO* Hemostatic Matrix THROMBIN EVITHROM* Thrombin, Topical (Human)
Fibrin Sealant Market Overview
U.S. Fibrin Market *IMS Data, 2007 Vitagel EVICEL Tisseel 2006 Fibrin Market ($92 MM) 2007 Fibrin Market ($103 MM est.) Total fibrin market grew by 12% in 2007 Source: IMS 2007
EVICEL Performance 2005 $183,364 $847,628 $1.2MM $1.9MM $2.2MM $2.2MM $3.1MM $3.6MM $4.2MM $5.3MM Launched  EVICEL Launched  CROSSEAL Launched  EVICEL Vascular 2006 2007 $6.1MM $8.4 MM $7.1 MM Launched  EVICEL General  Hemostasis $8.8MM 2008 $10.4MM YTD in 2007 vs  $17.7MM YTD in 2008 70% growth over 2007!!!
122% -15% 37% The Fibrin Sealants segment increased 18% over previous quarter and 14% over 4Q ’06 to $27.3M this quarter.  Evicel leads the growth, with almost $5M growth in the past year and $0.7M in the past quarter.  Although Tisseel is down over the past year, it rebounded in 4Q ’07 after its drop in 3Q ’07.  Tisseel is cannibalizing its VH (nonfrozen) business with the newer frozen formulations which now account for 22% of its total dollar volume US Biosurgicals Market: Fibrin Sealants Detailed Segment, Short-term  Dollar  Performance 3 Month Quarters, $ Volume, in Millions Growth  over  Pr. Yr. Segment Volume (MM) $3.9 $5.8 $8.2 $8.3 $8.8 $17.0 $17.5 $14.3 $11.4 $12.0 $3.5 $3.4 $2.9 $3.5 $4.0 $- $5 $10 $15 $20 $25 $30 4Q '06 1Q '07 2Q '07 3Q '07 4Q '07 $, Millions Evicel Tisseel Vitagel Source:  IMS HIS Data Compiled by:  Pinky Shaw, BIWW
Plastic/Burn Surgery Market Overview **NOTE:  As always, promotion only for on-label surgeries for hemostasis $764MM 1,038,000 TOTAL $338MM 735,000 Breast  (Reconstruction, Lift, Reduction and augmentation)   (5 mL) $100MM 100,000 Burn Surgery (10 mL) $240MM 160,000 Abdominoplasty (15 mL) $86MM 43,000 Massive Weight Loss Body Contouring (20 mL) Potential Market (100% Penetration) Volume Procedure
Procedures to Target ,[object Object],[object Object],[object Object],Plastic Procedures
Background & New Indication
J&J Collaboration Framework ,[object Object]
EVICEL General Hemostasis  Indication Expected in January 2008 ,[object Object],[object Object],[object Object],[object Object],[object Object]
New Opportunities in Plastic Surgery ,[object Object],[object Object],[object Object]
EVICEL Selling Cycle ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New Indication for EVICEL TM   EVICEL TM  Fibrin Sealant (Human) is indicated  as an adjunct to hemostasis for patients  undergoing  surgery  when control of bleeding by standard surgical techniques is ineffective or impractical * Pending final labeling from FDA
EVICEL ™  Fibrin Sealant (Human) Original Promotional Road Map Does the surgeon  operate on the liver? Sales rep  can also respond  to a training request Sales rep or Medical Affairs *  can respond to request for clinical info. Yes Yes You and the customer  can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can  you  (sales rep) initiate conversation  on EVICEL Fibrin Sealant (Human)  for the approved indication? Can  you  (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only  customers  can initiate questions  on EVICEL Fibrin Sealant (Human)  No Only  Medical Affairs *  can respond  to request for off-label clinical  information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product  Can  you  (sales rep) respond  to off-label clinical questions on  EVICEL Fibrin Sealant (Human)? Can  you  (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications,  Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
EVICEL ™  Fibrin Sealant (Human) Vascular Promotional Road Map Does the surgeon operate on the liver  or perform vascular surgery? Sales rep  can also respond  to a training request Sales rep or Medical Affairs *  can respond to request for clinical info. Yes Yes You and the customer  can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can  you  (sales rep) initiate conversation  on EVICEL Fibrin Sealant (Human)  for the approved indication? Can  you  (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only  customers  can initiate questions  on EVICEL Fibrin Sealant (Human)  No Only  Medical Affairs *  can respond  to request for off-label clinical  information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product  Can  you  (sales rep) respond  to off-label clinical questions on  EVICEL Fibrin Sealant (Human)? Can  you  (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications,  Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
EVICEL ™  Fibrin Sealant (Human) General Hemostasis Promotional Road Map Sales rep or Medical Affairs  can respond to request for clinical info. Yes Yes You and the customer  can initiate questions on EVICEL for the approved indication Can  you  (sales rep) initiate conversation  on EVICEL for the approved indication? Can  you  (sales rep) respond to clinical questions on EVICEL for the approved indication? Only  customers  can initiate questions  on EVICEL for off-label uses No, cannot promote for off-label uses, such as sealing and fixation Only  Medical Affairs  can respond  to request for off-label clinical  information on fibrin glues Can  you  (sales rep) respond  to off-label clinical questions on  EVICEL Fibrin Sealant (Human)? Can  you  (Sales rep) initiate conversation on off-label uses? No Training should include Indications, Contraindications,  Precautions, Warnings, and the technical aspects of the product. Promote On-label for Hemostasis? Does the surgeon perform surgery? Yes * Pending final labeling from FDA No
Customer Requests for Clinical Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Leverage our Broad GH Indication Retroperitoneal Bleeding/Soft Tissue (3) Peripheral Vascular Surgery (2) Liver Resection Surgery (1) General Hemostasis Indication Studied in 3 different tissue types
Soft Tissue Study Highlights ENDPOINTS / CONCLUSIONS ,[object Object],[object Object],[object Object],[object Object],[object Object],* Pending final labeling from FDA
Competitive Overview
US Indications Differ by Fibrin Sealant Brand 1, 2 - Sources:  US FDA Approved Package Inserts for Tisseel, Evicel TM   & Artiss Note: Information from respective prescribing information derived from separate clinical studies - not intended to convey comparative safety or efficacy.  ,[object Object],[object Object],TISSEEL  (Fibrin Sealant)  Pre-Filled Syringe (Frozen) (Baxter) Indication Statements ,[object Object],[object Object],ARTISS   (Fibrin Sealant)   (Baxter) Product ,[object Object]
Indications by Fibrin Sealant Sources:  US FDA Approved Package Inserts for Tisseel, Evicel TM   & Artiss Note: Information from respective prescribing information derived from separate clinical studies - not intended to convey comparative safety or efficacy.  To adhere autologous  skin grafts to surgically prepared  wound beds resulting from burns  Adjunct to hemostasis in patients undergoing surgeries involving Cardio- pulmonary bypass ,[object Object],[object Object],TISSEEL Not indicated for hemostasis ARTISS Adjunct to hemostasis for use in patients undergoing surgery Ortho Burns Plastics GYN Urology CV PV General
Fibrinogen & Thrombin Content*  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],*EVICEL TM   Fibrin Sealant (Human) Artiss & Tisseel Fibrin Sealant Package Inserts 1. Sierra D. Fibrin sealant adhesive systems: a review of their chemistry, material properties and clinical applications.  Journal of Applied Biomaterials. Vol.3. 1992: 147-151. Note:  Not intended to convey comparative safety or efficacy. EVICEL TM  Fibrin Sealant TISSEEL Fibrin Sealant ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ARTISS Fibrin Sealant EVICEL TM  does not contain aprotinin and does not expose patients to the risks associated with aprotinin EVICEL TM  does not require an antifibrinolytic stabilizer (ex: aprotinin)  agent due to the removal of plasminogen from its formulation Normal fibrin clot is produced with approximately 2–5 mg/mL of fibrinogen 1
Clot Longevity Comparison* Longevity of the EVICEL TM  Fibrin Sealant (Human) clot in vivo is comparable to that of CROSSEAL* Fibrin Sealant, and other marketed fibrin sealants such as Tisseel *Johnson & Johnson Wound Management Data on File, Data from in vitro animal model
EVICEL TM  Product Training
Think EVICEL TM  for your Plastic Surgery Procedures EVICEL TM  is the  first  and  only  fibrin sealant approved for general hemostasis in surgery 1 TRAM Flap Abdominoplasty Think 1.  Full Prescribing Information.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],EVICEL™ Fibrin Sealant (Human) INDICATION: An adjunct to hemostasis for use in patients undergoing surgery when control of bleeding by standard surgical techniques is ineffective or impractical Important Safety Information
EVICEL™ Fibrin Sealant (Human) ,[object Object],[object Object],[object Object],[object Object],A safe and effective all-human fibrin sealant that doesn’t require an antifibrinolytic agent, while maintaining  clot stability 1.  Full Prescribing Information. 2.  Data on File. ETHICON, INC.
EVICEL™ Fibrin Sealant (Human) ,[object Object],[object Object],[object Object],Hemostasis can begin quickly with less preparation time and minimal clogging Triple-lumen tip  —  resists clogging 1.  Full Prescribing Information. 2.  Data on File. ETHICON, INC. Thaws within 10 minutes at 37 0 C; within 1 hour at 20 0 C to 25 0 C (room temperature); or within 1 day at 2 0 C to 8 0 C (refrigerator).
EVICEL™ Fibrin Sealant (Human) ,[object Object],[object Object],[object Object],[object Object],[object Object],Designed to keep you focused on your procedure – Clear and stable clot 1 1.  Full Prescribing Information, see EVICEL TM  Package Insert 2.  Data on File. ETHICON, INC.
Biologics – Thrombin & BAC2 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1.  Full Prescribing Information.
Device Overview 2 luer locks for easy removal and  attachment of accessory tips  Triple lumen 7cm clog resistant applicator tip Optional 35cm  Rigid Tip Can be sprayed or dripped from the same device
35 cm Rigid Tip Overview EVICEL 35 cm Rigid Tip Packaging (3 per box) Ready to spray or drip One-Handed delivery Atraumatic & clog-resistant tip (triple lumen runs throughout tip) Attaches easily to the device
Pressure Regulator EVICEL TM  Fibrin Sealant (Human) should be sprayed using  an air pressure of 20–25 psi measured by air flow* * EVICEL TM  Fibrin Sealant (Human) Pressure Regulator Instructions for Use
Preparation Video
EVICEL™ Fibrin Sealant (Human)  Summary 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],1.  Full Prescribing Information.
Plastic Surgery Sales Tools
Updated Main Sales Aid NOW  the  only  fibrin sealant approved for general hemostasis in surgery New Effective Bullet: Proven Rapid Hemostasis in vascular, urologic, gynecologic and  general surgery New Soft Tissue Study   data   in general, gynecologic and urologic surgery * Pending final labeling from FDA; Draft Piece-Subject to change
New  Plastics  Slim Jim  Plastics Images (Breast Reconstruction) Hemostatic Efficacy (New Soft Tissue Study Data) in general, gynecologic and urologic surgery Experience the   clear choice   for your plastic surgery  procedures Spray or drip EVICEL™ to achieve hemostasis during reconstructive procedures, including:  breast reconstruction, abdominoplasty, facial reconstruction and vascular anastomoses * Subject to FDA Review * Pending final labeling from FDA; Draft Piece-Subject to change
Customer Requests for Clinical Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Product Preparation Poster New Cling-zee OR Wall Poster Easy preparation: No mixing required New easy-to-see images Preparation instructions for the 35 cm Rigid Tip
EVICEL Product Codes
New Customer In-service Deck (Updated with new indication & modular device) New Updated Website (New specialty tabs in Ortho, Burns & Plastics) New Blackberry Videos (3 new videos in Ortho, Burns & Plastics)
EVICEL in Plastic Surgery Overview
Plastic & Burn Specialty Overview
Why I Use Fibrin Sealants  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Where I Use Fibrin Sealant ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],Abdominoplasty Steps of Procedure &  Bleeding Challenges
Abdominoplasty ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Breast Reconstruction – Flap ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Breast Reconstruction – Implant ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Facial Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scar Revision ,[object Object],Bleeding Challenges
Scar Revision ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],For Internal Use Only
Scar Revision
Surgery Videos
Breast Reconstruction
Q&A
[object Object]
[object Object]
2008 Goals Develop new customers and markets (Ortho, Plastics & Burns) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Capture   competitive market share Create  new markets Protect   our existing business Maintain & Protect our existing business - Main Sales Aid   - Product Monograph   - FDA approval letter    - Press Release   - Plastics Slim Jim   - Burn Slim Jim   - Ortho Slim Jim Sales Tools: Sales Tools:   - Contracting Strategy   - Main Sales Aid   Sales Tools:
Burn Surgery ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

REBOA
REBOAREBOA
REBOA
degnarog
 
Coagulopathy in trauma patients
Coagulopathy in trauma patientsCoagulopathy in trauma patients
Coagulopathy in trauma patients
Dr.Mahmoud Abbas
 
Future of RF Ablation: Continuous or Segmental?
Future of RF Ablation: Continuous or Segmental?Future of RF Ablation: Continuous or Segmental?
Future of RF Ablation: Continuous or Segmental?
Vein Global
 
Cabg with lima rima
Cabg with lima rimaCabg with lima rima
Tea Talk about MRCS.pptx
Tea Talk about MRCS.pptxTea Talk about MRCS.pptx
Tea Talk about MRCS.pptx
Samia Farhin
 
Blood & Blood Products
Blood & Blood ProductsBlood & Blood Products
Blood & Blood Products
Laxinys
 
Vascular surgery for dummies: clinical evaluation
Vascular surgery for dummies: clinical evaluationVascular surgery for dummies: clinical evaluation
Vascular surgery for dummies: clinical evaluation
HappyFridayKnight
 
Shiber REBOA
Shiber REBOAShiber REBOA
Shiber REBOA
UFJaxEMS
 
QUIZ
QUIZ QUIZ
Novel Fractionation Technologies INTERPHEX
Novel Fractionation Technologies INTERPHEXNovel Fractionation Technologies INTERPHEX
Novel Fractionation Technologies INTERPHEX
Dieter Fassnacht, PhD, PMP
 
Damage Control in Trauma by Brohi
Damage Control in Trauma by BrohiDamage Control in Trauma by Brohi
Damage Control in Trauma by Brohi
SMACC Conference
 
Damage Control Resuscitation
Damage  Control  ResuscitationDamage  Control  Resuscitation
Damage Control Resuscitation
Mazen Yazan Kherallah
 
History of surgery
History of surgeryHistory of surgery
History of surgery
Nikhil Nanjappa
 
Endovascular Prep Basic
Endovascular Prep BasicEndovascular Prep Basic
Endovascular Prep Basic
Dicky A Wartono
 
Groin management 2013
Groin management 2013Groin management 2013
Groin management 2013
Cardiac Cath Lab Information
 
Closure devices
Closure devicesClosure devices
Closure devices
Balakumaran Jeyakumaran
 
Drug eluting stent
Drug eluting stentDrug eluting stent
Drug eluting stent
Ramachandra Barik
 
Wound healing dr sumer
Wound healing   dr sumerWound healing   dr sumer
Wound healing dr sumer
Sumer Yadav
 
Vascular implants & grafts
Vascular implants & graftsVascular implants & grafts
Vascular implants & grafts
Institute of chemical Technology, Mumbai
 
Bone tissue engineering
Bone tissue engineeringBone tissue engineering
Bone tissue engineering
Mehdi Chamani
 

What's hot (20)

REBOA
REBOAREBOA
REBOA
 
Coagulopathy in trauma patients
Coagulopathy in trauma patientsCoagulopathy in trauma patients
Coagulopathy in trauma patients
 
Future of RF Ablation: Continuous or Segmental?
Future of RF Ablation: Continuous or Segmental?Future of RF Ablation: Continuous or Segmental?
Future of RF Ablation: Continuous or Segmental?
 
Cabg with lima rima
Cabg with lima rimaCabg with lima rima
Cabg with lima rima
 
Tea Talk about MRCS.pptx
Tea Talk about MRCS.pptxTea Talk about MRCS.pptx
Tea Talk about MRCS.pptx
 
Blood & Blood Products
Blood & Blood ProductsBlood & Blood Products
Blood & Blood Products
 
Vascular surgery for dummies: clinical evaluation
Vascular surgery for dummies: clinical evaluationVascular surgery for dummies: clinical evaluation
Vascular surgery for dummies: clinical evaluation
 
Shiber REBOA
Shiber REBOAShiber REBOA
Shiber REBOA
 
QUIZ
QUIZ QUIZ
QUIZ
 
Novel Fractionation Technologies INTERPHEX
Novel Fractionation Technologies INTERPHEXNovel Fractionation Technologies INTERPHEX
Novel Fractionation Technologies INTERPHEX
 
Damage Control in Trauma by Brohi
Damage Control in Trauma by BrohiDamage Control in Trauma by Brohi
Damage Control in Trauma by Brohi
 
Damage Control Resuscitation
Damage  Control  ResuscitationDamage  Control  Resuscitation
Damage Control Resuscitation
 
History of surgery
History of surgeryHistory of surgery
History of surgery
 
Endovascular Prep Basic
Endovascular Prep BasicEndovascular Prep Basic
Endovascular Prep Basic
 
Groin management 2013
Groin management 2013Groin management 2013
Groin management 2013
 
Closure devices
Closure devicesClosure devices
Closure devices
 
Drug eluting stent
Drug eluting stentDrug eluting stent
Drug eluting stent
 
Wound healing dr sumer
Wound healing   dr sumerWound healing   dr sumer
Wound healing dr sumer
 
Vascular implants & grafts
Vascular implants & graftsVascular implants & grafts
Vascular implants & grafts
 
Bone tissue engineering
Bone tissue engineeringBone tissue engineering
Bone tissue engineering
 

Viewers also liked

H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller
 
O’Hare Modernization Program
O’Hare Modernization ProgramO’Hare Modernization Program
O’Hare Modernization Program
Center for Neighborhood Technology
 
Khalid.ppt
Khalid.pptKhalid.ppt
Khalid.ppt
khalid wani
 
Gums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants TechnologyGums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants Technology
Ajjay Kumar Gupta
 
Tissue sealant essentials
Tissue sealant essentialsTissue sealant essentials
Tissue sealant essentials
BALASUBRAMANIAM IYER
 
Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...
Ken Research Pvt ltd.
 
Topical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practiceTopical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practice
anemo_site
 
Brick Classification
Brick ClassificationBrick Classification
Brick Classification
Steve Jarvis
 
Hemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusionHemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusion
Mae Martinquilla
 
Bricks fin
Bricks finBricks fin
Bricks fin
Karthik Yadavalli
 
Construction Sealants
Construction SealantsConstruction Sealants
Construction Sealants
Pintu Badatiya
 
Business plan on fly ash bricks
Business plan on fly ash bricksBusiness plan on fly ash bricks
Business plan on fly ash bricks
Atikant Kashyap
 
Classification of bricks as per conventional standard
Classification of bricks as per conventional standardClassification of bricks as per conventional standard
Classification of bricks as per conventional standard
dezyneecole
 
Bricks
Bricks Bricks
Brics ppt
Brics pptBrics ppt
Brics ppt
Anushka Kapoor
 

Viewers also liked (16)

H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
H.B. Fuller state of the U.S. Adhesive and Sealant Market 2014
 
O’Hare Modernization Program
O’Hare Modernization ProgramO’Hare Modernization Program
O’Hare Modernization Program
 
Khalid.ppt
Khalid.pptKhalid.ppt
Khalid.ppt
 
Gums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants TechnologyGums, Adhesives & Sealants Technology
Gums, Adhesives & Sealants Technology
 
Tissue sealant essentials
Tissue sealant essentialsTissue sealant essentials
Tissue sealant essentials
 
Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...Clay brick making machine industry,indian bricks sector,indian brick industry...
Clay brick making machine industry,indian bricks sector,indian brick industry...
 
Topical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practiceTopical hemostatic agents in surgical practice
Topical hemostatic agents in surgical practice
 
Brick Classification
Brick ClassificationBrick Classification
Brick Classification
 
Hemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusionHemostasis, surgical bleeding and transfusion
Hemostasis, surgical bleeding and transfusion
 
Bricks fin
Bricks finBricks fin
Bricks fin
 
Construction Sealants
Construction SealantsConstruction Sealants
Construction Sealants
 
Business plan on fly ash bricks
Business plan on fly ash bricksBusiness plan on fly ash bricks
Business plan on fly ash bricks
 
Classification of bricks as per conventional standard
Classification of bricks as per conventional standardClassification of bricks as per conventional standard
Classification of bricks as per conventional standard
 
Bricks
Bricks Bricks
Bricks
 
Brics ppt
Brics pptBrics ppt
Brics ppt
 
Testovi sa resenjima
Testovi sa resenjimaTestovi sa resenjima
Testovi sa resenjima
 

Similar to Plastics

Action proposal
Action proposalAction proposal
Action proposal
Jake Radzak
 
HIV Lipoatrophy 2007
HIV Lipoatrophy 2007HIV Lipoatrophy 2007
HIV Lipoatrophy 2007
VHCONCEPTS
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Fight Colorectal Cancer
 
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical CenterSUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
GoLeanSixSigma.com
 
Exercise No 4 How To Label Intravenous Fluid
Exercise  No 4    How To  Label  Intravenous  FluidExercise  No 4    How To  Label  Intravenous  Fluid
Exercise No 4 How To Label Intravenous Fluid
dunerafael
 
Surgical safety checklist issued by who
Surgical safety checklist issued by whoSurgical safety checklist issued by who
Surgical safety checklist issued by who
Vin Williams
 
Bioheart (OTC: BHRT; Twitter: $BHRT)
Bioheart (OTC: BHRT; Twitter: $BHRT)Bioheart (OTC: BHRT; Twitter: $BHRT)
Bioheart (OTC: BHRT; Twitter: $BHRT)
ProActive Capital Resources Group
 
MLSS Investor Presentation August 2021
MLSS Investor Presentation August 2021MLSS Investor Presentation August 2021
MLSS Investor Presentation August 2021
RedChip Companies, Inc.
 
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
International Chair on Interventional Cardiology and Transradial Approach
 
10 step marketing plan for aforvir
10 step marketing plan for aforvir10 step marketing plan for aforvir
10 step marketing plan for aforvir
Ralph Raymund Pinon
 
MLSS Investor Presentation June 2021
MLSS Investor Presentation June 2021MLSS Investor Presentation June 2021
MLSS Investor Presentation June 2021
RedChip Companies, Inc.
 
Macrolane Breast Enhancement - Paris
Macrolane Breast Enhancement  - ParisMacrolane Breast Enhancement  - Paris
Macrolane Breast Enhancement - Paris
AuroraClinics
 
erbitux
erbituxerbitux
erbitux
eman youssif
 
MLSS Investor Presentation October2021
MLSS Investor Presentation October2021MLSS Investor Presentation October2021
MLSS Investor Presentation October2021
RedChip Companies, Inc.
 
The Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in SpainThe Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in Spain
European Industrial Pharmacists Group
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014
Pete Shuster
 
Evolence Dermal Filler
Evolence Dermal FillerEvolence Dermal Filler
Evolence Dermal Filler
Dr. Patrick J. Treacy
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Training
guestaa38de
 
Resumegreg
ResumegregResumegreg
Resumegreg
guesta2940e
 
Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021
RedChip Companies, Inc.
 

Similar to Plastics (20)

Action proposal
Action proposalAction proposal
Action proposal
 
HIV Lipoatrophy 2007
HIV Lipoatrophy 2007HIV Lipoatrophy 2007
HIV Lipoatrophy 2007
 
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
Drug Types: Biosimilars, generics and more. December 2017 Webinar 12122017
 
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical CenterSUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
SUCCESS STORY: How Lean Six Sigma Saved $4 Million at UCSD Medical Center
 
Exercise No 4 How To Label Intravenous Fluid
Exercise  No 4    How To  Label  Intravenous  FluidExercise  No 4    How To  Label  Intravenous  Fluid
Exercise No 4 How To Label Intravenous Fluid
 
Surgical safety checklist issued by who
Surgical safety checklist issued by whoSurgical safety checklist issued by who
Surgical safety checklist issued by who
 
Bioheart (OTC: BHRT; Twitter: $BHRT)
Bioheart (OTC: BHRT; Twitter: $BHRT)Bioheart (OTC: BHRT; Twitter: $BHRT)
Bioheart (OTC: BHRT; Twitter: $BHRT)
 
MLSS Investor Presentation August 2021
MLSS Investor Presentation August 2021MLSS Investor Presentation August 2021
MLSS Investor Presentation August 2021
 
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. FischellPCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
PCI & AimRadial 2018 | Innovation in Cardiovascular Medicine - Tim A. Fischell
 
10 step marketing plan for aforvir
10 step marketing plan for aforvir10 step marketing plan for aforvir
10 step marketing plan for aforvir
 
MLSS Investor Presentation June 2021
MLSS Investor Presentation June 2021MLSS Investor Presentation June 2021
MLSS Investor Presentation June 2021
 
Macrolane Breast Enhancement - Paris
Macrolane Breast Enhancement  - ParisMacrolane Breast Enhancement  - Paris
Macrolane Breast Enhancement - Paris
 
erbitux
erbituxerbitux
erbitux
 
MLSS Investor Presentation October2021
MLSS Investor Presentation October2021MLSS Investor Presentation October2021
MLSS Investor Presentation October2021
 
The Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in SpainThe Future of the Pharmaceutical Industry in Spain
The Future of the Pharmaceutical Industry in Spain
 
Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014Regenerative Medicine Industry Outlook 2014
Regenerative Medicine Industry Outlook 2014
 
Evolence Dermal Filler
Evolence Dermal FillerEvolence Dermal Filler
Evolence Dermal Filler
 
cGMP Case Study Training
cGMP Case Study TrainingcGMP Case Study Training
cGMP Case Study Training
 
Resumegreg
ResumegregResumegreg
Resumegreg
 
Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021Milestone Scientific Inc. Investor Presentation April 2021
Milestone Scientific Inc. Investor Presentation April 2021
 

Recently uploaded

The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
heathfieldcps1
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
Celine George
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
Nicholas Montgomery
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
adhitya5119
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
RAHUL
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
WaniBasim
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Fajar Baskoro
 
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
sayalidalavi006
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
ak6969907
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
Nicholas Montgomery
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
Dr. Shivangi Singh Parihar
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
Priyankaranawat4
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
Dr. Mulla Adam Ali
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Excellence Foundation for South Sudan
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
PECB
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 

Recently uploaded (20)

The basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptxThe basics of sentences session 6pptx.pptx
The basics of sentences session 6pptx.pptx
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17How to Fix the Import Error in the Odoo 17
How to Fix the Import Error in the Odoo 17
 
writing about opinions about Australia the movie
writing about opinions about Australia the moviewriting about opinions about Australia the movie
writing about opinions about Australia the movie
 
Advanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docxAdvanced Java[Extra Concepts, Not Difficult].docx
Advanced Java[Extra Concepts, Not Difficult].docx
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPLAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UP
 
Liberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdfLiberal Approach to the Study of Indian Politics.pdf
Liberal Approach to the Study of Indian Politics.pdf
 
Pengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptxPengantar Penggunaan Flutter - Dart programming language1.pptx
Pengantar Penggunaan Flutter - Dart programming language1.pptx
 
Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5Community pharmacy- Social and preventive pharmacy UNIT 5
Community pharmacy- Social and preventive pharmacy UNIT 5
 
World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024World environment day ppt For 5 June 2024
World environment day ppt For 5 June 2024
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
Film vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movieFilm vocab for eal 3 students: Australia the movie
Film vocab for eal 3 students: Australia the movie
 
PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.PCOS corelations and management through Ayurveda.
PCOS corelations and management through Ayurveda.
 
clinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdfclinical examination of hip joint (1).pdf
clinical examination of hip joint (1).pdf
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
Hindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdfHindi varnamala | hindi alphabet PPT.pdf
Hindi varnamala | hindi alphabet PPT.pdf
 
Your Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective UpskillingYour Skill Boost Masterclass: Strategies for Effective Upskilling
Your Skill Boost Masterclass: Strategies for Effective Upskilling
 
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 

Plastics

  • 1. EVICEL Fibrin Sealant (Human) Product Information EVICEL TM Fibrin Sealant (Human) PSR Sales Training Module
  • 2.
  • 3. Biosurgicals Products EVICEL* FIBRIN SEALANT (HUMAN) ORC (Oxidized Regenerated Cellulose) GELATIN FLOWABLE GELATIN COLLAGEN FIBRIN SEALANT SURGICEL* Hemostats SURGICEL FIBRILLAR* Hemostats SURGICEL NU-KNIT* Hemostats SURGIFOAM* GELATIN SPONGE & POWDER Hemostats INSTAT* MICROFIBRILLARCOLLAGEN Hemostats SURGIFOAM* POWDER Kit SURGIFLO* Hemostatic Matrix THROMBIN EVITHROM* Thrombin, Topical (Human)
  • 5. U.S. Fibrin Market *IMS Data, 2007 Vitagel EVICEL Tisseel 2006 Fibrin Market ($92 MM) 2007 Fibrin Market ($103 MM est.) Total fibrin market grew by 12% in 2007 Source: IMS 2007
  • 6. EVICEL Performance 2005 $183,364 $847,628 $1.2MM $1.9MM $2.2MM $2.2MM $3.1MM $3.6MM $4.2MM $5.3MM Launched EVICEL Launched CROSSEAL Launched EVICEL Vascular 2006 2007 $6.1MM $8.4 MM $7.1 MM Launched EVICEL General Hemostasis $8.8MM 2008 $10.4MM YTD in 2007 vs $17.7MM YTD in 2008 70% growth over 2007!!!
  • 7. 122% -15% 37% The Fibrin Sealants segment increased 18% over previous quarter and 14% over 4Q ’06 to $27.3M this quarter. Evicel leads the growth, with almost $5M growth in the past year and $0.7M in the past quarter. Although Tisseel is down over the past year, it rebounded in 4Q ’07 after its drop in 3Q ’07. Tisseel is cannibalizing its VH (nonfrozen) business with the newer frozen formulations which now account for 22% of its total dollar volume US Biosurgicals Market: Fibrin Sealants Detailed Segment, Short-term Dollar Performance 3 Month Quarters, $ Volume, in Millions Growth over Pr. Yr. Segment Volume (MM) $3.9 $5.8 $8.2 $8.3 $8.8 $17.0 $17.5 $14.3 $11.4 $12.0 $3.5 $3.4 $2.9 $3.5 $4.0 $- $5 $10 $15 $20 $25 $30 4Q '06 1Q '07 2Q '07 3Q '07 4Q '07 $, Millions Evicel Tisseel Vitagel Source: IMS HIS Data Compiled by: Pinky Shaw, BIWW
  • 8. Plastic/Burn Surgery Market Overview **NOTE: As always, promotion only for on-label surgeries for hemostasis $764MM 1,038,000 TOTAL $338MM 735,000 Breast (Reconstruction, Lift, Reduction and augmentation) (5 mL) $100MM 100,000 Burn Surgery (10 mL) $240MM 160,000 Abdominoplasty (15 mL) $86MM 43,000 Massive Weight Loss Body Contouring (20 mL) Potential Market (100% Penetration) Volume Procedure
  • 9.
  • 10. Background & New Indication
  • 11.
  • 12.
  • 13.
  • 14.
  • 15. New Indication for EVICEL TM EVICEL TM Fibrin Sealant (Human) is indicated as an adjunct to hemostasis for patients undergoing surgery when control of bleeding by standard surgical techniques is ineffective or impractical * Pending final labeling from FDA
  • 16. EVICEL ™ Fibrin Sealant (Human) Original Promotional Road Map Does the surgeon operate on the liver? Sales rep can also respond to a training request Sales rep or Medical Affairs * can respond to request for clinical info. Yes Yes You and the customer can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can you (sales rep) initiate conversation on EVICEL Fibrin Sealant (Human) for the approved indication? Can you (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only customers can initiate questions on EVICEL Fibrin Sealant (Human) No Only Medical Affairs * can respond to request for off-label clinical information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product Can you (sales rep) respond to off-label clinical questions on EVICEL Fibrin Sealant (Human)? Can you (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications, Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
  • 17. EVICEL ™ Fibrin Sealant (Human) Vascular Promotional Road Map Does the surgeon operate on the liver or perform vascular surgery? Sales rep can also respond to a training request Sales rep or Medical Affairs * can respond to request for clinical info. Yes Yes You and the customer can initiate questions on EVICEL Fibrin Sealant (Human) for the approved indication Can you (sales rep) initiate conversation on EVICEL Fibrin Sealant (Human) for the approved indication? Can you (sales rep) respond to clinical questions on EVICEL Fibrin Sealant (Human) for the approved indication? Yes Only customers can initiate questions on EVICEL Fibrin Sealant (Human) No Only Medical Affairs * can respond to request for off-label clinical information on fibrin glue Sales rep could provide proper usage instructions upon request (including indications & safety information) to customers who decide to use the product Can you (sales rep) respond to off-label clinical questions on EVICEL Fibrin Sealant (Human)? Can you (Sales rep) initiate conversation on EVICEL Fibrin Sealant (Human)? No Training should include Indications, Contraindications, Precautions, Warnings, and the technical aspects of the product. * Pending final labeling from FDA No
  • 18. EVICEL ™ Fibrin Sealant (Human) General Hemostasis Promotional Road Map Sales rep or Medical Affairs can respond to request for clinical info. Yes Yes You and the customer can initiate questions on EVICEL for the approved indication Can you (sales rep) initiate conversation on EVICEL for the approved indication? Can you (sales rep) respond to clinical questions on EVICEL for the approved indication? Only customers can initiate questions on EVICEL for off-label uses No, cannot promote for off-label uses, such as sealing and fixation Only Medical Affairs can respond to request for off-label clinical information on fibrin glues Can you (sales rep) respond to off-label clinical questions on EVICEL Fibrin Sealant (Human)? Can you (Sales rep) initiate conversation on off-label uses? No Training should include Indications, Contraindications, Precautions, Warnings, and the technical aspects of the product. Promote On-label for Hemostasis? Does the surgeon perform surgery? Yes * Pending final labeling from FDA No
  • 19.
  • 20. Leverage our Broad GH Indication Retroperitoneal Bleeding/Soft Tissue (3) Peripheral Vascular Surgery (2) Liver Resection Surgery (1) General Hemostasis Indication Studied in 3 different tissue types
  • 21.
  • 23.
  • 24.
  • 25.
  • 26. Clot Longevity Comparison* Longevity of the EVICEL TM Fibrin Sealant (Human) clot in vivo is comparable to that of CROSSEAL* Fibrin Sealant, and other marketed fibrin sealants such as Tisseel *Johnson & Johnson Wound Management Data on File, Data from in vitro animal model
  • 27. EVICEL TM Product Training
  • 28. Think EVICEL TM for your Plastic Surgery Procedures EVICEL TM is the first and only fibrin sealant approved for general hemostasis in surgery 1 TRAM Flap Abdominoplasty Think 1. Full Prescribing Information.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34. Device Overview 2 luer locks for easy removal and attachment of accessory tips Triple lumen 7cm clog resistant applicator tip Optional 35cm Rigid Tip Can be sprayed or dripped from the same device
  • 35. 35 cm Rigid Tip Overview EVICEL 35 cm Rigid Tip Packaging (3 per box) Ready to spray or drip One-Handed delivery Atraumatic & clog-resistant tip (triple lumen runs throughout tip) Attaches easily to the device
  • 36. Pressure Regulator EVICEL TM Fibrin Sealant (Human) should be sprayed using an air pressure of 20–25 psi measured by air flow* * EVICEL TM Fibrin Sealant (Human) Pressure Regulator Instructions for Use
  • 38.
  • 40. Updated Main Sales Aid NOW the only fibrin sealant approved for general hemostasis in surgery New Effective Bullet: Proven Rapid Hemostasis in vascular, urologic, gynecologic and general surgery New Soft Tissue Study data in general, gynecologic and urologic surgery * Pending final labeling from FDA; Draft Piece-Subject to change
  • 41. New Plastics Slim Jim Plastics Images (Breast Reconstruction) Hemostatic Efficacy (New Soft Tissue Study Data) in general, gynecologic and urologic surgery Experience the clear choice for your plastic surgery procedures Spray or drip EVICEL™ to achieve hemostasis during reconstructive procedures, including: breast reconstruction, abdominoplasty, facial reconstruction and vascular anastomoses * Subject to FDA Review * Pending final labeling from FDA; Draft Piece-Subject to change
  • 42.
  • 43. Product Preparation Poster New Cling-zee OR Wall Poster Easy preparation: No mixing required New easy-to-see images Preparation instructions for the 35 cm Rigid Tip
  • 45. New Customer In-service Deck (Updated with new indication & modular device) New Updated Website (New specialty tabs in Ortho, Burns & Plastics) New Blackberry Videos (3 new videos in Ortho, Burns & Plastics)
  • 46. EVICEL in Plastic Surgery Overview
  • 47. Plastic & Burn Specialty Overview
  • 48.
  • 49.
  • 50.
  • 51.
  • 52.
  • 53.
  • 54.
  • 55.
  • 56.
  • 60. Q&A
  • 61.
  • 62.
  • 63.
  • 64.

Editor's Notes

  1. Looks okay as is.